Carrington Smith, CEO

Carrington has over 20 years of experience in the industrial and chemical sectors providing business leadership, management, technology and commercialization solutions in a range of roles spanning technology management, business development, M&A analysis and execution, venture capital, open innovation, intellectual asset management and IP licensing. Carrington joined MPD Chemicals in February of 2014, as CEO. Prior to MPD Chemicals, Carrington held various leadership and managerial roles at Air Products and Chemicals, Inc. for over 20 years, creating value for advanced technologies, business case construction, valuations, contract negotiation, building company relationships, and making the complex simple. He also directed initiatives with start-ups and other large companies to generate collaborative relationships and generate business growth.

Carrington began his industrial career with Air Products and Chemicals, Inc. in a research and development role, having earned his BS in Chemistry from Virginia Commonwealth University and a Ph.D. in Chemistry with a focus on polymer science from Virginia Tech. Polymer development for gas separation membranes, electronic materials, adhesives and coatings were all part of Carrington’s early research and product development career at Air Products. He enjoys working with customers and partners to identify win-win relationships built on credibility, transparency and trust by leveraging the capabilities of MPD Chemicals, at the highest level, to provide custom chemical synthesis solutions. “Our customers desire critical enabling materials development, often starting with laboratory procedures and scales. Customers prefer to work with partners like us, who are willing and able to provide a pathway to economics that works for their application and who can remain a consistent supplier from lab to large scale multi-metric ton production. We are proud to serve an excellent current set of large and small customers with a diverse array of custom chemical solutions, and are excited about our future customer prospects as well. We serve an important and differentiated role bridging contract research type projects to pilot and large scale manufacturing capabilities, all within the same organization. ”

Don Morrison,  VP, Business Development, Sales & Marketing

Don is responsible for Business Development, Sales, and Marketing initiatives at MPD Chemicals. He earned his Ph. D. in Organometallic Chemistry from the University of Arizona, performed post-doctoral studies at the Max-Planck Institute, and has an M.B.A. from Colorado State University. Don has solid skills which enable him to solve both technical and business issues for customers and can visualize solutions to the chemistry and engineering aspects of new product development. Don joined Norquay in 2016 after serving in many roles ranging from R&D, Sales, Operations and Business Development at companies including Union Carbide, The Dow Chemical Company, and Boulder Scientific Company. In addition to his broad knowledge of several industries, he brings his ability to learn and adapt as new situations develop to help take products from customer concept to commercialization.

John Shibley, Vice President

John Shibley joined Silar Laboratories in 1993 as the site manager of its Scotia, NY laboratory R&D and production facility. In 2009, he was named President of Silar Laboratories after Silar’s purchase by MPD Holdings. Previously, he was the business manager of Silar while Silar was owned by Wright Corporation and Oak-Bark Corporation. For over 20 years at Silar, John managed process development, scale-up, new product development, commercialization, manufacturing, and business management. John earned a BS in Chemistry from Rensselaer Polytechnic Institute, a PhD in Inorganic Chemistry from the University of Wisconsin-Madison, and an MBA from the University of North Carolina-Wilmington.

Rich Tyburski, President

As President of IsoSciences since July 2016, Rich oversees IsoSciences R&D, Operations, Custom Synthesis, and the development and production of over 1,000 novel catalog offerings for the clinical diagnostics and pharmaceutical markets. Rich has worked with diagnostic, nutritional, pharmaceutical and government laboratories around the world to produce the highest quality internal standards available.

He leads IsoSciences as a key manufacture for stable isotope labeled materials in the rapidly expanding market utilizing LC-MS/MS analysis. IsoSciences fulfills the market need for stable isotope labeled analytes, advanced intermediates, final drug substances and metabolites. IsoSciences has ensured customer requirements are met by using advanced processes and stringent quality specifications. Rich has experience in custom synthesis, analysis and ISO9001 Quality System implementation. Prior to his role as President, he was Vice President of Business Development, demonstrating success in expanding IsoSciences core business of new product development.

Prior to joining IsoSciences in 2007, Rich worked at Quest Pharmaceutical Services as a Staff Scientist specializing in LC-MS/MS GLP bio-equivalency studies. Rich obtained his bachelor’s degree in chemistry from Villanova University.